These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28231940)

  • 1. Reply: Heart Rate Reduction and Cardiovascular Outcome in Hypertension.
    Messerli FH; Rimoldi SF; Bangalore S; Bavishi C; Laurent S
    J Am Coll Cardiol; 2017 Feb; 69(8):1100-1101. PubMed ID: 28231940
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart Rate Reduction and Cardiovascular Outcome in Hypertension.
    Palatini P
    J Am Coll Cardiol; 2017 Feb; 69(8):1099-1100. PubMed ID: 28231939
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular profile of BR 750 (2,6-dichlorobenzylideneaminoguanidine acetate).
    Saini RK; Caputi AP; Marmo E
    Farmaco Prat; 1973 Jul; 28(7):359-87. PubMed ID: 4724740
    [No Abstract]   [Full Text] [Related]  

  • 4. Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular events.
    Fragasso G; Cera M; Margonato A
    J Am Coll Cardiol; 2009 Jun; 53(22):2105; author reply 2106-7. PubMed ID: 19477370
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-blocker-induced heart rate reduction: too simplistic to explain the deleterious effects of beta-blockers.
    Laurent S; Boutouyrie P
    J Am Coll Cardiol; 2009 Jun; 53(22):2103-4; author reply 2106-7. PubMed ID: 19477367
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart rate lowering by beta-blockade and cardiovascular events.
    Messerli FH; Rimoldi SF; Bangalore S
    J Hypertens; 2016 Oct; 34(10):2102-3. PubMed ID: 27579706
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.
    Wustmann K; Kucera JP; Scheffers I; Mohaupt M; Kroon AA; de Leeuw PW; Schmidli J; Allemann Y; Delacrétaz E
    Hypertension; 2009 Sep; 54(3):530-6. PubMed ID: 19620513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker-induced heart rate lowering, cardioprotection, and hypertension.
    Khan SS
    J Am Coll Cardiol; 2009 Jun; 53(22):2104-5; author reply 2106-7. PubMed ID: 19477368
    [No Abstract]   [Full Text] [Related]  

  • 9. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system.
    Guzik P; Wykretowicz A; Krauze T; Piskorski J; Adamska K; Milewska A; Wesseling KH; Wysocki H
    Hypertens Res; 2008 Mar; 31(3):443-53. PubMed ID: 18497463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers and hypertension.
    Cruickshank JM
    J Am Coll Cardiol; 2009 Jun; 53(22):2105-6; author reply 2106-7. PubMed ID: 19477369
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of Blood Pressure and Heart Rate in Chronic Kidney Disease.
    Kaltsatou A
    Curr Pharm Des; 2017; 23(31):4603-4608. PubMed ID: 28875847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers as first-line antihypertensive therapy the crumbling continues.
    Lavie CJ; Messerli FH; Milani RV
    J Am Coll Cardiol; 2009 Sep; 54(13):1162-4. PubMed ID: 19761937
    [No Abstract]   [Full Text] [Related]  

  • 13. Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs.
    Palatini P
    Drugs; 1999 May; 57(5):713-24. PubMed ID: 10353296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GABA and central regulation of cardiovascular function].
    Bousquet P; Feldman J; Schwartz J
    J Pharmacol; 1985; 16 Suppl 2():29-50. PubMed ID: 2867251
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
    Nobre F; da Silva CA; Coelho EB; Salgado HC; Fazan R
    Am J Hypertens; 2006 Oct; 19(10):1079-83. PubMed ID: 17027832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.
    Bangalore S; Sawhney S; Messerli FH
    J Am Coll Cardiol; 2008 Oct; 52(18):1482-9. PubMed ID: 19017516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinaemia-induced cardiovascular changes in rats.
    Resstel LB; de Andrade CR; Haddad R; Eberlin MN; de Oliveira AM; Corrêa FM
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):949-56. PubMed ID: 18430058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.
    Palatini P; Benetos A; Julius S
    Drugs; 2006; 66(2):133-44. PubMed ID: 16451089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular adaptation to mudpack therapy in hypertensive subjects treated with different antihypertensive drugs.
    Merati G; Agnello L; Rampichini S; Maggioni MA; Scurati R; Veicsteinas A
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2544-50. PubMed ID: 25268103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of tetrandrine on the left ventricular function and the peripheral blood vessels in canine.
    Zeng F; Fang D; Leng D; Lu F
    Acta Acad Med Wuhan; 1982; 2(3):154. PubMed ID: 7167264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.